Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells

被引:224
作者
Wu, Annie A. [1 ]
Drake, Virginia [2 ]
Huang, Huai-Shiuan [3 ]
Chiu, ShihChi [3 ]
Zheng, Lei [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[3] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
关键词
immunosuppression; immunotherapy; immunosuppressive factors; T cells; tumor microenvironment; GROWTH-FACTOR-BETA; BCL-X-L; INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; MYELOID SUPPRESSOR-CELLS; SMALL-MOLECULE INHIBITOR; PROSTATE-CANCER CELLS; HUMAN-MELANOMA CELLS; DOWN-REGULATION; IMMUNE-RESPONSES; GENE-EXPRESSION;
D O I
10.1080/2162402X.2015.1016700
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has become evident that tumor-induced immunosuppressive factors in the tumor microenvironment play a major role in suppressing normal functions of effector T cells. These factors serve as hurdles that limit the therapeutic potential of cancer immunotherapies. This review focuses on illustrating the molecular mechanisms of immunosuppression in the tumor microenvironment, including evasion of T-cell recognition, interference with T-cell trafficking, metabolism, and functions, induction of resistance to T-cell killing, and apoptosis of T cells. A better understanding of these mechanisms may help in the development of strategies to enhance the effectiveness of cancer immunotherapies.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 276 条
[11]  
Baj-Krzyworzeka Monika, 2004, Cancer Immun, V4, P8
[12]   Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis [J].
Banh, Alice ;
Zhang, Jing ;
Cao, Hongbin ;
Bouley, Donna M. ;
Kwok, Shirley ;
Kong, Christina ;
Giaccia, Amato J. ;
Koong, Albert C. ;
Le, Quynh-Thu .
CANCER RESEARCH, 2011, 71 (13) :4423-4431
[13]  
Belicha-Villanueva A., 2008, REGULATION CLASSICAL
[14]   RETRACTED: Immunosuppressive networks in the tumour environment and their effect in dendritic cells (Retracted article. See vol. 1835, pg. 259, 2013) [J].
Bennaceur, Karim ;
Chapman, Jessica Alice ;
Touraine, Jean-louis ;
Portoukalian, Jacques .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1795 (01) :16-24
[15]  
BETZ M, 1991, J IMMUNOL, V146, P108
[16]   Selection for beta(2)-microglobulin mutation in mismatch repair-defective colorectal carcinomas [J].
Bicknell, DC ;
Kaklamanis, L ;
Hampson, R ;
Bodmer, WF ;
Karran, P .
CURRENT BIOLOGY, 1996, 6 (12) :1695-1697
[17]   GM2 expression in renal cell carcinoma: Potential role in tumor-induced T-cell dysfunction [J].
Biswas, Kaushik ;
Richmond, Amy ;
Rayman, Patricia ;
Biswas, Soumika ;
Thornton, Mark ;
Sa, Gaurisankar ;
Das, Tanya ;
Zhang, Renliang ;
Chahlavi, Ali ;
Tannenbaum, Charles S. ;
Novick, Andrew ;
Bukowski, Ronald ;
Finke, James H. .
CANCER RESEARCH, 2006, 66 (13) :6816-6825
[18]   Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction [J].
Biswas, Soumika ;
Biswas, Kaushik ;
Richmond, Amy ;
Ko, Jennifer ;
Ghosh, Sankar ;
Simmons, Matthew ;
Rayman, Patricia ;
Rini, Brian ;
Gill, Inderbir ;
Tannenbaum, Charles S. ;
Finke, James H. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (08) :5050-5058
[19]   HOW DOES IT ACT WHEN SOLUBLE? CRITICAL EVALUATION OF MECHANISM OF GALECTIN-1 INDUCED T-CELL APOPTOSIS [J].
Blasko, Andrea ;
Fajka-Boja, Roberta ;
Ion, Gabriela ;
Monostori, Eva .
ACTA BIOLOGICA HUNGARICA, 2011, 62 (01) :106-111
[20]   Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO [J].
Blesson, S ;
Thiery, J ;
Gaudin, C ;
Stancou, R ;
Kolb, JP ;
Moreau, JL ;
Theze, J ;
Mami-Chouaib, F ;
Chouaib, S .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (10) :1169-1178